OPC Pharmaceutical JSC (HOSE:OPC)

Market Cap	1.50T
Revenue (ttm)	951.23B
Net Income (ttm)	86.16B
Shares Out	64.05M
EPS (ttm)	1,345.00
PE Ratio	17.40
Forward PE	n/a
Dividend	1,500.00 (6.41%)
Ex-Dividend Date	n/a

Volume	4,100
Average Volume	6,550
Open	23,500
Previous Close	23,500
Day's Range	23,100 - 23,500
52-Week Range	22,150 - 27,000
Beta	0.17
RSI	47.85
Earnings Date	Jan 24, 2025

About OPC Pharmaceutical JSC

OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally. The company offers cardiovascular, nerve, vitamins and minerals, respiratory system, urinary, musculoskeletal system, external use, digestion, pain relief-inflammation, endocrine, and others drugs. It also offers health gifts; and nutrition products for health care, supplementing nutrients, nourishing the body, and boosting immunity. In addition, the...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 926
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: OPC

Financial Performance

In 2023, OPC Pharmaceutical JSC's revenue was 1.00 trillion, a decrease of -14.23% compared to the previous year's 1.17 trillion. Earnings were 104.69 billion, a decrease of -18.29%.